Bahrain Makes History with First Successful CRISPR-Based Sickle Cell Treatment Outside the US
MANAMA, Kingdom of Bahrain, Feb. 16, 2025 (GLOBE NEWSWIRE) -- The Bahrain Oncology Centre (BOC) has made medical history by...
Month: February 2025
FAU Joins the Nation’s Most Elite Research Universities and Colleges
Carnegie Classification of Institutions of Higher Education Designates FAU as 'R1: Very High Research Spending and Doctorate Production' BOCA RATON,...
REPEAT/MEDIA ADVISORY – Patients who have been extra-billed for surgeries in private for-profit clinics demand accountability in the Ontario election: Press conferences in towns across Ontario
TORONTO, OTTAWA, LONDON and WINDSOR, Ontario, Feb. 15, 2025 (GLOBE NEWSWIRE) -- The Ontario Health Coalition is holding press conferences...
Asa Gudmundsdottir Wright Award Presented as Plans for New Icelandic Academy of Science & Innovation Announced
Recognizing Contributions to Science and InnovationREYKJAVIK, Iceland--(BUSINESS WIRE)--#kerecis--Iceland’s President, Halla Tomasdottir, presented the Asa Gudmundsdottir Wright Award at a ceremony...
NanoVibronix, Inc. Announces Acquisition of ENvue Medical Holdings, Corp.
ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company”), a medical technology company specializing in non-invasive therapeutic devices, today announced the...
Weave Now Integrates with Practice Fusion
New integration unlocks Weave features to help streamline communication workflowsLEHI, Utah--(BUSINESS WIRE)--Weave (NYSE: WEAV), a leading all-in-one customer experience and...
Establishment Labs to Announce Fourth Quarter 2024 Financial Results on February 26
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness,...
New Era Notifies Individuals of a Security Incident
HOUSTON, Feb. 14, 2025 /PRNewswire/ -- New Era Life Insurance Companies ("New Era")1 recently began notifying individuals of a security...
Ledger Run Announces CEO Transition
Gary Lubin, Ledger Run's Founder and CEO, to retire and will continue on Board John Chinnici appointed as CEO for...
Ketamine: From club drug to antidepressant?
Cold Spring Harbor Laboratory Professor Hiro Furukawa and postdoc Hyunook Kang prove the existence of a mysterious brain receptor known...
Agentic AI Startup, VoiceCare AI, Launches to Automate Healthcare Back Office and Super-Staff Workforce
Company Raises $3.85M in Seed Funding led by Caduceus Capital Partners, with Participation from Bread and Butter Ventures; Announces Collaboration...
Datasea Reports Second Fiscal Quarter 2025 Revenue of $20.5 Million, Up 81.4% Year-over-Year
Datasea's Top Line Growth Fueled by the Expansion of its State-of-the-Art 5G+AI Multimodal Digital Segment in China BEIJING, Feb. 14,...
SS&C Announces Common Stock Dividend of $0.25 Per Share
WINDSOR, Conn., Feb. 14, 2025 /PRNewswire/ -- SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced its Board of Directors has approved a...
IT-Harvest Selected for 2025 Google for Startups Growth Academy: AI for Cybersecurity
BIRMINGHAM, Mich., Feb. 14, 2025 /PRNewswire/ -- IT-Harvest is proud to announce its selection for the 2025 Google for Startups...
NeuralCure AI Announces Breakthrough in AI-Powered Healthcare, Completing Decades of Medical Research in Moments
Company Opens Fundraising Round to Scale AI-Driven Diagnostics & Treatment Simulations DENVER, Feb. 14, 2025 /PRNewswire/ -- NeuralCure AI, an emerging...
Safety Strips Invites Media Offices to Receive Free Fentanyl Test Kits to Enhance Public Safety
Providing Journalists and Event Organizers with Essential Tools for Overdose PreventionToronto, Ontario--(Newsfile Corp. - February 14, 2025) - Safe Supply...
Ensho Therapeutics Announces Upcoming Presentation at ECCO 2025 of Phase 1, Once-Daily Dosing Data for NSHO-101, an Oral α4β7 Inhibitor for Inflammatory Bowel Disease
MORRIS PLAINS, N.J., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Ensho Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company focused on...
IN8bio Presents Positive Phase 1 Data at TCT 2025, Highlighting Durability of Remissions in High-Risk AML
NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) -- February 14, 2025 – IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing...
Artelo Biosciences Announces New Data on ART12.11 Tablets Showing Improved Pharmacokinetics to Epidiolex®
SOLANA BEACH, Calif., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on...
OraSure to Announce Fourth Quarter 2024 Financial Results and Host Earnings Call on February 25th
BETHLEHEM, Pa., Feb. 14, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call...